Complete financial analysis of Neogen Chemicals Limited (NEOGEN.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Neogen Chemicals Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Falck Renewables S.p.A. (FKR.MI) Income Statement Analysis – Financial Results
- Kinder Morgan, Inc. (0JR2.L) Income Statement Analysis – Financial Results
- Daiwa Office Investment Corporation (8976.T) Income Statement Analysis – Financial Results
- Speedy Hire Plc (SDY.L) Income Statement Analysis – Financial Results
- Bharat Parenterals Limited (BPLPHARMA.BO) Income Statement Analysis – Financial Results
Neogen Chemicals Limited (NEOGEN.NS)
About Neogen Chemicals Limited
Neogen Chemicals Limited manufactures and sells specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds, unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; inorganic bromine compounds and lithium salts; grignard reagents; and advance intermediates. The company also provides custom synthesis and manufacturing services. It serves pharmaceutical, agrochemical, engineering, flavour and fragrance, electronic-chemical, refrigeration, construction chemicals, pharmaceutical, and specialty polymer industries, as well as heating, ventilation, and air-conditioning industries. The company also exports its products to 28 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.91B | 6.86B | 4.87B | 3.36B | 3.06B | 2.39B | 1.61B | 1.10B | 1.00B | 839.19M | 738.10M |
| Cost of Revenue | 4.04B | 3.89B | 3.47B | 2.39B | 2.18B | 1.71B | 1.16B | 788.31M | 746.90M | 615.56M | 546.04M |
| Gross Profit | 2.87B | 2.98B | 1.40B | 969.86M | 881.39M | 681.77M | 449.14M | 312.36M | 256.11M | 223.63M | 192.06M |
| Gross Profit Ratio | 41.49% | 43.38% | 28.69% | 28.83% | 28.79% | 28.52% | 27.87% | 28.38% | 25.53% | 26.65% | 26.02% |
| Research & Development | 34.90M | 56.60M | 47.00M | 29.37M | 20.41M | 14.01M | 8.91M | 6.02M | 4.61M | 4.23M | 4.88M |
| General & Administrative | 127.30M | 144.70M | 108.50M | 75.02M | 76.38M | 52.47M | 28.30M | 23.95M | 23.13M | 22.18M | 21.43M |
| Selling & Marketing | 177.30M | 142.80M | 111.20M | 50.51M | 52.01M | 79.42M | 43.91M | 32.08M | 40.32M | 27.27M | 20.87M |
| SG&A | 304.60M | 287.50M | 219.70M | 125.53M | 128.40M | 131.89M | 72.21M | 56.03M | 63.45M | 49.45M | 42.30M |
| Other Expenses | 1.95B | 44.50M | 1.30M | 16.00K | 15.00K | 1.86M | 42.40M | 290.00K | 20.00K | 480.00K | 2.67M |
| Operating Expenses | 2.29B | 2.02B | 651.60M | 395.29M | 353.28M | 271.80M | 178.62M | 123.61M | 118.82M | 106.41M | 85.90M |
| Cost & Expenses | 6.01B | 5.91B | 4.13B | 2.79B | 2.53B | 1.98B | 1.34B | 911.92M | 865.72M | 721.97M | 631.94M |
| Interest Income | 74.10M | 38.70M | 5.50M | 1.37M | 977.00K | 1.07M | 2.15M | 1.57M | 1.60M | 1.95M | 1.43M |
| Interest Expense | 420.60M | 289.40M | 178.00M | 129.33M | 109.57M | 112.48M | 98.54M | 66.11M | 41.94M | 44.12M | 44.03M |
| Depreciation & Amortization | 228.70M | 162.00M | 116.90M | 69.02M | 52.42M | 28.37M | 18.52M | 13.11M | 9.98M | 9.34M | 9.22M |
| EBITDA | 1.13B | 1.16B | 876.60M | 644.96M | 582.63M | 440.29M | 296.94M | 203.33M | 142.72M | 136.54M | 118.86M |
| EBITDA Ratio | 16.42% | 16.93% | 17.67% | 19.04% | 18.72% | 18.21% | 17.80% | 17.72% | 14.25% | 15.58% | 15.68% |
| Operating Income | 871.80M | 999.70M | 228.30M | 574.57M | 528.11M | 409.97M | 270.52M | 188.75M | 137.29M | 117.22M | 106.16M |
| Operating Income Ratio | 12.62% | 14.57% | 4.69% | 17.08% | 17.25% | 17.15% | 16.79% | 17.15% | 13.69% | 13.97% | 14.38% |
| Total Other Income/Expenses | -344.10M | -243.90M | -180.10M | -136.29M | -117.14M | -117.42M | -97.16M | -73.69M | -52.48M | -36.57M | -44.27M |
| Income Before Tax | 527.70M | 710.30M | 570.10M | 442.16M | 410.97M | 292.54M | 173.35M | 115.06M | 84.81M | 80.65M | 61.89M |
| Income Before Tax Ratio | 7.64% | 10.35% | 11.70% | 13.14% | 13.42% | 12.24% | 10.76% | 10.45% | 8.46% | 9.61% | 8.39% |
| Income Tax Expense | 171.20M | 210.60M | 124.40M | 128.84M | 124.40M | 83.07M | 68.38M | 38.23M | 33.01M | 29.80M | 25.46M |
| Net Income | 356.50M | 499.70M | 446.30M | 313.30M | 286.57M | 209.47M | 104.97M | 76.83M | 51.80M | 50.85M | 36.43M |
| Net Income Ratio | 5.16% | 7.28% | 9.16% | 9.31% | 9.36% | 8.76% | 6.51% | 6.98% | 5.16% | 6.06% | 4.94% |
| EPS | 13.96 | 20.04 | 17.90 | 13.43 | 12.28 | 10.43 | 5.25 | 3.83 | 2.58 | 2.53 | 1.81 |
| EPS Diluted | 13.96 | 20.04 | 17.90 | 13.43 | 12.28 | 10.43 | 5.25 | 3.83 | 2.58 | 2.53 | 1.81 |
| Weighted Avg Shares Out | 25.54M | 24.94M | 24.94M | 23.34M | 23.33M | 20.08M | 20.00M | 20.00M | 20.00M | 20.08M | 20.08M |
| Weighted Avg Shares Out (Dil) | 25.54M | 24.94M | 24.94M | 23.34M | 23.33M | 20.08M | 20.00M | 20.08M | 20.08M | 20.08M | 20.08M |
Source: https://incomestatements.info
Category: Stock Reports